John Dodd
Acute Care · Tifton, GANPI 1003104670
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,560 and has fallen 52.1% since, to $747 in 2025. Among acute care clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$751
- Johnson & Johnson$580
- Merck$400
- E.r. Squibb & Sons, L.L.C.$390
- Amgen$343
- Novartis$317
- plus $2K from 15 others
What the payments were for
- Food & beverage$4,544100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 50 | $751 |
| Johnson & Johnson | 29 | $580 |
| Merck | 23 | $400 |
| E.r. Squibb & Sons, L.L.C. | 20 | $390 |
| Amgen | 19 | $343 |
| Novartis | 19 | $317 |
| Boehringer Ingelheim | 9 | $312 |
| AstraZeneca(2 entities) | 18 | $292 |
| Medtronic | 10 | $227 |
| Boston Scientific | 12 | $213 |
| Daiichi Sankyo Inc. | 8 | $165 |
| Amarin Pharma, Inc. | 7 | $136 |
| Alnylam Pharmaceuticals Inc. | 5 | $101 |
| Esperion Therapeutics, Inc. | 5 | $91 |
| Lexicon Pharmaceuticals, Inc. | 3 | $58 |
| Bayer | 3 | $52 |
| Nuwellis, Inc. | 2 | $30 |
| Scpharmaceuticals Inc. | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Bridgebio Pharma, Inc. | 1 | $21 |
| Vital Connect, Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,544 in reported general payments places this provider in the 95th percentile of 679 acute care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 96 | $95,822 |
| EntrestoSacubitril/Valsartan | 35 | $37,287 |
| FarxigaDapagliflozin Propanediol | 36 | $23,199 |
| XareltoRivaroxaban | 22 | $22,865 |
| Clonidine | 14 | $3,363 |
| Ranolazine ErRanolazine | 13 | $1,652 |
| Midodrine Hcl | 27 | $1,008 |
| Metoprolol Succinate | 26 | $713 |
| Atorvastatin Calcium | 60 | $519 |
| ClopidogrelClopidogrel Bisulfate | 39 | $458 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 24 | $431 |
| Diltiazem 24hr ErDiltiazem Hcl | 14 | $387 |
| SotalolSotalol Hcl | 31 | $347 |
| Furosemide | 83 | $318 |
| Ezetimibe | 12 | $280 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $751 | $95,82296 claims |
| NovartisEntresto | $317 | $37,28735 claims |
| AstraZenecaFarxiga | $292 | $23,19936 claims |
| Johnson & JohnsonXarelto | $580 | $22,86522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 679 acute care providers in Georgia.
Other acute care in Tifton
- Zoye McDonaldTifton$3K
- Darryl TurnerRinggold$21K
- Bryce CowgillCumming$16K
- Stacy CreelSavannah$15K
- Susan BeitzellAthens$13K
- Crystal KuhnCumming$12K
- Mark ClarkGainesville$10K
- Sarah WymanAtlanta$10K
- Jeffrey DillerAustell$10K
- Ayeshia PowellAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.